Estimating uncertainty in LLNA EC3 data and its impact on regulatory classifications

Area of Science:

• Toxicology
• Chemical Safety Assessment
• Regulatory Science

Background:

• The murine Local Lymph Node Assay (LLNA) provides EC3 values crucial for chemical sensitization potency classification.
• Regulatory decisions heavily rely on LLNA data, yet uncertainty in EC3 values is often overlooked.
• Limited new experimental EC3 data necessitates robust methods for analyzing existing datasets.

Purpose of the Study:

• To investigate the impact of uncertainty in murine Local Lymph Node Assay (LLNA) EC3 values on chemical classification.
• To propose and evaluate alternative statistical distributions for assessing variability in EC3 data.
• To analyze the implications of EC3 uncertainty for regulatory decision-making.

Main Methods:

• Applied two strictly positive distributions to assess variability in experimental EC3 values, comparing them to the default Gaussian distribution.
• Analyzed the effect of EC3 value uncertainty on chemical classification outcomes.
• Determined the percentage of chemicals with ambiguous classifications.

Main Results:

• The study identified a high percentage of chemicals receiving ambiguous classifications due to EC3 value uncertainty.
• The use of alternative distributions highlighted potential risks of improper classification.
• The Gaussian distribution may not adequately capture the variability in EC3 data.

Conclusions:

• Uncertainty in EC3 values poses a significant risk of misclassification for chemical sensitization.
• Regulatory approaches incorporating "grey zones" or classification distributions can mitigate risks associated with ambiguous classifications.
• The classification distribution approach offers a viable method for assessing sensitization potency when unambiguous classification is not possible, aiding regulatory practice.